Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model
Author(s) -
ChengPeng Sun,
Junjun Zhou,
Zhenlong Yu,
Xiaokui Huo,
Juan Zhang,
Christophe Morisseau,
Bruce D. Hammock,
Xiaochi Ma
Publication year - 2022
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2118818119
Subject(s) - parkinson's disease , pharmacology , disease , medicine , neuroscience , traditional medicine , chemistry , psychology
Significance To date, no cure or preventative treatment for Parkinson’s disease (PD) has yet been developed. Here, we show that kurarinone, a natural flavonoid, alleviated parkinsonism-like symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Using a proteomics approach, we identified the soluble epoxide hydrolase (sEH) as a possible target of kurarinone’s reduction of neuroinflammation. This was supported using complementary biochemical approaches, which demonstrated that kurarinone is a high nanomolar uncompetitive inhibitor of sEH. Our findings suggest that natural products could attenuate the development of PD through inhibition of sEH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom